Diabetic foot ulcers are among the most persistent and costly complications of diabetes, and a substantial proportion resist closure with standard dressings alone. When a wound is large, deep, heavily exuding, or slow to progress, clinicians increasingly turn to negative pressure wound therapy (NPWT) as an adjunct to conventional care. Understanding how NPWT works, what the evidence supports, and where its limits lie helps patients, caregivers, and clinicians set realistic expectations for wound healing.
What Negative Pressure Wound Therapy Is
NPWT applies controlled sub-atmospheric pressure to a wound through a sealed dressing connected to a vacuum pump. A foam or gauze filler is placed into the wound bed, covered with an airtight film, and connected via tubing to a canister that collects fluid. The pump then applies a carefully regulated negative pressure, typically continuous or intermittent, drawing wound and tissue fluid away from the treated area.
The therapy is thought to promote healing through several mechanisms: reducing localized edema and excess exudate, increasing local blood flow, mechanically drawing the wound edges together, and stimulating the formation of granulation tissue—the vascular connective tissue that fills a healing wound. Because NPWT manages exudate within a closed system, it can also reduce the frequency of dressing changes compared with traditional methods.
What the Evidence Shows
The strongest cautionary appraisal comes from the Cochrane systematic review by Liu and colleagues (Cochrane Database of Systematic Reviews, 2018), which pooled randomized trials of NPWT for diabetic foot wounds. The review concluded that there is low-certainty evidence that NPWT increases the proportion of wounds that heal compared with standard dressings, and may shorten healing time. Importantly, the authors emphasized that the overall reliability of the trial evidence was limited, meaning the true size of any benefit remains uncertain.
More recent meta-analyses have reinforced a generally favorable, though still qualified, picture. A meta-analysis published in the World Journal of Diabetes (2024) reported higher healing rates and reduced wound size with NPWT relative to conventional treatment. A systematic review and meta-analysis in the Journal of Clinical Medicine (2025) analyzing overlapping randomized trials found that NPWT was associated with significantly higher odds of wound healing, with a pooled odds ratio of roughly 3.6 in a fixed-effects analysis. A further systematic review in the Journal of Diabetes & Metabolic Disorders (2026) synthesizing trials from 2020 onward found that NPWT significantly reduced wound closure time and accelerated recovery, without a notable increase in complications.
Post-Amputation and Complex Wounds
NPWT has a particularly established role in the management of open wounds following partial foot amputation. Across the literature, post-amputation wounds treated with NPWT have shown higher rates of complete healing than those managed with conventional moist dressings, and several syntheses have linked NPWT use to reductions in the need for further, more proximal amputation. These complex, high-exudate wounds—where a well-vascularized granulating bed must form over exposed deep tissue—are precisely the scenario in which the mechanical and fluid-management effects of NPWT appear most useful.
Where NPWT Fits in Overall Care
NPWT is an adjunct, not a standalone cure. It is applied only after thorough wound bed preparation, which includes surgical debridement of nonviable tissue and control of any active infection. It cannot compensate for uncorrected ischemia; wounds with significant peripheral arterial disease generally require assessment for revascularization before or alongside advanced wound therapies. Adequate offloading of plantar pressure and optimization of blood glucose remain foundational, because no dressing system can overcome continued mechanical trauma or poor metabolic control.
The therapy is not appropriate for every wound. Contraindications and cautions include untreated osteomyelitis, the presence of malignancy in the wound, exposed blood vessels or organs, and inadequately controlled bleeding. Practical limitations—maintaining an airtight seal on the contoured surfaces of the foot, device cost, and the need for patient adherence to wearing the system—also influence whether NPWT is suitable in a given case.
Key Takeaways
Negative pressure wound therapy is a well-established adjunctive option for diabetic foot ulcers that are large, deep, heavily exuding, or slow to heal, and for open wounds after partial foot amputation. Current evidence, spanning the Cochrane review and multiple more recent meta-analyses, points to improved healing rates, faster wound closure, and potential reductions in amputation, though the certainty of some of this evidence remains modest and continued high-quality trials are needed. NPWT works best as one component of comprehensive care—following debridement and infection control, alongside vascular assessment, offloading, and glycemic management—rather than as a replacement for these fundamentals. Careful patient selection, attention to contraindications, and realistic expectations are essential to using the therapy effectively.
References
Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2018.
Efficacy and safety of negative pressure wound therapy for the treatment of diabetic foot ulcers: a meta-analysis. World Journal of Diabetes. 2024.
Comparative Efficacy of Negative Pressure Wound Therapy and Conventional Treatments in the Management of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025.
A systematic review of randomized controlled trials assessing the efficacy of negative pressure wound therapy in diabetic foot wounds. Journal of Diabetes & Metabolic Disorders. 2026.
Chen L, et al. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer. Annals of Palliative Medicine. 2021.
Comments
